GHRH and benign prostatic hyperplasia: Effects of the GH-RH antagonist, JMR-132 (40 μg/day), the LH-RH antagonist, Cetrorelix (0.625 mg/kg), and their combination were evaluated on testosterone-induced BPH in male Wistar rats.